Page last updated: 2024-08-24

plerixafor and Bone Loss, Osteoclastic

plerixafor has been researched along with Bone Loss, Osteoclastic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Hatano-Sato, K; Hosomichi, J; Ishida, Y; Li, K; Mahatumarat, K; Ongprakobkul, N; Ono, T; Petdachai, S; Usumi-Fujita, R1
Chen, A; Cheng, P; Dong, Y; Guo, F; Huang, H; Liu, H; Qin, L; Xu, F; Yang, Q; Zhang, X1
Apicelli, A; Eagleton, MC; Hirbe, AC; Morgan, EA; Piwnica-Worms, D; Prior, JL; Trinkaus, K; Uluçkan, O; Weilbaecher, K1

Other Studies

3 other study(ies) available for plerixafor and Bone Loss, Osteoclastic

ArticleYear
Effects of local vs systemic administration of CXCR4 inhibitor AMD3100 on orthodontic tooth movement in rats.
    American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics, 2022, Volume: 162, Issue:2

    Topics: Animals; Benzylamines; Bone Resorption; Cathepsin K; Core Binding Factor Alpha 1 Subunit; Cyclams; Osteoclasts; Rats; Receptors, CXCR4; Tooth Movement Techniques; X-Ray Microtomography

2022
Inhibition of SDF-1α/CXCR4 Signalling in Subchondral Bone Attenuates Post-Traumatic Osteoarthritis.
    International journal of molecular sciences, 2016, Jun-16, Volume: 17, Issue:6

    Topics: Animals; Benzylamines; Biomarkers; Bone and Bones; Bone Remodeling; Bone Resorption; Cartilage, Articular; Cell Differentiation; Chemokine CXCL12; Cyclams; Disease Models, Animal; Gene Expression; Heterocyclic Compounds; Male; Mice; Osteoarthritis; Osteoclasts; Receptors, CXCR4; Signal Transduction; Wounds and Injuries; X-Ray Microtomography

2016
Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner.
    Blood, 2007, Apr-15, Volume: 109, Issue:8

    Topics: Animals; Anti-HIV Agents; Benzylamines; Bone Density; Bone Neoplasms; Bone Resorption; Cell Movement; Cyclams; Granulocyte Colony-Stimulating Factor; Heterocyclic Compounds; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neutropenia; Neutrophils; Osteoclasts; Receptors, CXCR4; Tumor Burden

2007